First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans ; volume:20 ; number:1 ; day:8 ; month:12 ; year:2022 ; pages:1-10 ; date:12.2022
Pediatric rheumatology ; 20, Heft 1 (8.12.2022), 1-10, 12.2022
- Creator
-
Beukelman, Timothy
Tomlinson, George
Nigrovic, Peter A.
Dennos, Anne
Gaizo, Vincent Del
Jelinek, Marian
Riordan, Mary Ellen
Schanberg, Laura E.
Mohan, Shalini
Pfeifer, Erin
Kimura, Yukiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-022-00768-6
- URN
-
urn:nbn:de:101:1-2023021809000057689921
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beukelman, Timothy
- Tomlinson, George
- Nigrovic, Peter A.
- Dennos, Anne
- Gaizo, Vincent Del
- Jelinek, Marian
- Riordan, Mary Ellen
- Schanberg, Laura E.
- Mohan, Shalini
- Pfeifer, Erin
- Kimura, Yukiko
- SpringerLink (Online service)
Other Objects (12)
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
Juvenile Idiopathic Arthritis: Diagnosis and Treatment
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease
Early treatment with infliximabin patients with juvenile idiopathic arthritis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Juvenile idiophathische Arthritis
Juvenile idiopathische Arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Eight years of experience with biological treatment in juvenile idiopathic arthritis
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
Juvenile Idiopathic Arthritis: Diagnosis and Treatment
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease
Early treatment with infliximabin patients with juvenile idiopathic arthritis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Juvenile idiophathische Arthritis
Juvenile idiopathische Arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Eight years of experience with biological treatment in juvenile idiopathic arthritis
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
Juvenile Idiopathic Arthritis: Diagnosis and Treatment
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease
Early treatment with infliximabin patients with juvenile idiopathic arthritis
Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Juvenile idiophathische Arthritis
Juvenile idiopathische Arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis